Predictors of mortality for patients with COVID-19 and large vessel occlusion

• Published in: Interventional neuroradiology 2020-10, Vol.26 (5), p.623-628
• Main Authors: Altschul, David J, Esenwa, Charles, Haranhalli, Neil, Unda, Santiago R, de La Garza Ramos, Rafael, Dardick, Joseph, Fernandez-Torres, Jenelys, Toma, Aureliana, Labovitz, Daniel, Cheng, Natalie, Lee, Seon-Kyu, Brook, Allan, Zampolin, Richard
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases - mortality; Cohort Studies; Coronavirus Infections - complications; Coronavirus Infections - mortality; COVID-19; Female; Ferritins - blood; Fibrin Fibrinogen Degradation Products - analysis; Hospital Mortality; Humans; Lung Diseases - etiology; Lung Diseases - mortality; Male; Middle Aged; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - mortality; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Smoking - mortality; Stroke; Stroke - etiology; Stroke - mortality; Treatment Outcome
• ISSN: 1591-0199; 2385-2011
• DOI: 10.1177/1591019920954603

Background This study evaluates the mortality risk of patients with emergent large vessel occlusion (ELVO) and COVID-19 during the pandemic. Methods We performed a retrospective cohort study of two cohorts of consecutive patients with ELVO admitted to a quaternary hospital from March 1 to April 17, 2020. We abstracted data from electronic health records on baseline, biomarker profiles, key time points, quality measures and radiographic data. Results Of 179 patients admitted with ischemic stroke, 36 had ELVO. Patients with COVID-19 and ELVO had a higher risk of mortality during the pandemic versus patients without COVID-19 (OR 16.63, p = 0.004). An age-based sub-analysis showed in-hospital mortality in 60% of COVID-19 positive patients between 61-70 years-old, 66.7% in between 51-60 years-old, 50% in between 41-50 years-old and 33.3% in between 31-40 years old. Patients that presented with pulmonary symptoms at time of stroke presentation had 71.4% mortality rate. 27.3% of COVID-19 patients presenting with ELVO had a good outcome at discharge (mRS 0-2). Patients with a history of cigarette smoking (p = 0.003), elevated d-dimer (p = 0.007), failure to recanalize (p = 0.007), and elevated ferritin levels (p = 0.006) had an increased risk of mortality. Conclusion Patients with COVID-19 and ELVO had a significantly higher risk for mortality compared to COVID-19 negative patients with ELVO. A small percentage of COVID-19 ELVO patients had good outcomes. Age greater than 60 and pulmonary symptoms at presentation have higher risk for mortality. Other risk factors for mortality were a history of cigarette smoking, elevated, failure to recanalize, elevated d-dimer and ferritin levels.